Encore publishes data on impact of Nexus on COPD patients 

LIVINGSTON, Tenn. – Home-based COPD management programs led by respiratory therapists using AI-driven software with plan of care goals can have a significant impact on admissions, quality of care metrics and overall cost of care, according to an abstract developed by Encore Healthcare and published by the American Thoracic Society.  

HME providers using Encore’s Nexus software for patients using non-invasive ventilation produced the following results: 

• Enrollees who reported at least one hospitalization in the 12-month prior to enrollment experienced 65% fewer admissions post-enrollment 

• It total, patients experienced 34,029 fewer hospitalizations while enrolled in the program vs. the prior year 

• Using a standard DRG-related reimbursement of $7,500 for a COPD-related hospital stay, the program has resulted in an estimated total U.S. health care cost savings of more than $225 million 

The results are based on 17,394 home-based COPD patients managed from January 2018 to October 2023. 

In another abstract, HME providers using Encore’s Nexus software for patients using home oxygen therapy produced the following results: 

• Calculated as a per patient per month rate, enrolled patients experienced 94% fewer admissions vs. their 12-month prior history 

• In total, patients experienced 1,156 fewer hospitalizations while enrolled in the program vs. the prior year 

• Using a standard DRG-related reimbursement of $7,500 for a COPD-related hospital stay, the program has resulted in an estimated total U.S. Health care cost savings of more than $8.6 million 

These results are based on 30,950 COPD and chronic lung supplemental oxygen patients managed from May 2021 to October 2023. 

Read more about the abstracts here.